“A Role for Suzetrigine in the Management of Moderate to Severe Acute Pain”
Webinar/Online
Thursday, November 20, 2025 at 6:00pm CT - 7:30pm CT
Add this event to your calendar
Posted by The Greater Kansas City Chapter of ASPMN
CNEInfo
Topic
New drug on the market for acute pain - suzetrigine (Journavx)
Credits Offered
This event offers
1.3 CNE credits
to attendees
(1.3 pharmacology)
.
Accreditation Info:
Greater Kansas City Chapter of the American Society for Pain Management Nursing is approved provider of continuing nursing education by the Kansas State Board of Nursing. This course offering is approved for 1.3 CNE with 1.3 CNE Pharmacology for APNs. Provider Number: LT0279-0412GKCC605.
Attachments
Speakers
Senior Medical Science Liaison - Pain | Neuroscientist
Sam Dolzani, PhD is a medical science liaison on Vertex Pharmaceuticals’ pain team. Sam has over 15 years of experience across academic and industry settings. His professional experience includes National Institutes of Health-sponsored neuroscience research and roles within the commercial or medical affairs divisions of Abbott, Johnson and Johnson, Biohaven, Pfizer, and Vertex Pharmaceuticals. He earned his PhD and Master’s in Neuroscience from the University of Colorado, where his research focused on the neural circuitry underlying stress-related psychiatric disorders (i.e., depression, anxiety, and PTSD), neuroinflammation, and pain. Sam has coauthored 9 peer-reviewed neuroscience publications.